Sandoz publishes supplement to Listing Prospectus including Sandoz H1 2023 financial statements
Sandoz today published a supplement to its Listing Prospectus of August 18, 2023, ahead of an Extraordinary General Meeting (EGM) of Novartis shareholders. Scheduled to take place on September 15, 2023, the EGM has been called after the Novartis Board…
Optum and Capella University Announce New Nurse Practitioner Program To Address the Growing National Need for Skilled Clinicians
Optum, a diversified health services company, and Capella University, an accredited online university, announced a new educational program designed to address the growing need for skilled, advanced practice nurses. The collaboration will pair Capella’s unique educational capabilities with Optum’s clinical…
Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced new, 10-year long-term follow-up (LTFU) data published in the peer reviewed journal, Pediatrics, for girls and boys who received a three-dose regimen of GARDASIL®9 (Human Papillomavirus 9-valent Vaccine,…
CVS Health expands access to life-saving medication naloxone by offering over-the-counter NARCAN
Following FDA approval, CVS Pharmacy® is now offering over-the-counter (OTC) naloxone, brand name NARCAN®, at more than 7,500 locations nationwide, making it easier and more discrete than ever to purchase the safe and effective antidote to opioid overdoses. What is naloxone? Available…
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business, and Suneet Varma, Global Oncology and U.S. President, at the…
CerroZone™ Meets and Exceeds Requirements of ASHRAE Standard 241-2023, Control of Infectious Aerosols
CerroZone™ LLC’s air purification platforms have become the first to meet and exceed the requirements for Air Purifiers set out in the recently published ASHRAE Standard 241-2023 Control of Infectious Aerosols The same system previously earned 510(k) Class II clearance…
JAMA Publishes Two Large Studies Demonstrating the Diagnostic Accuracy of EarliTec’s Evaluation for Autism Spectrum Disorder in Children as Young as 16 Months
EarliTec Diagnostics, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism and related early childhood vulnerabilities, today announced that The Journal of the American Medical Association (JAMA) published positive results from a Phase III trial demonstrating…
Springboard Enterprises Announces 17 Members of Inaugural 2023 Digital Health Council
Springboard Enterprises, an organization with more than two decades of accelerating the growth of women-led start-ups has announced its inaugural 2023 Digital Health Council. The Council includes a diverse group of distinguished industry leaders from healthcare, life sciences, and technology,…
Lightning Step Names Healthcare IT Veteran Brent Michael as New CEO
Lightning Step, a leading provider of all-in-one CRM, EMR, and RCM solutions for behavioral health and addiction treatment centers, today announced it has appointed Brent Michael as its new Chief Executive Officer (CEO). With over three decades of experience in…
MultiPlan Announces New Additions to Senior Leadership Team
MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of Melissa Humphrey…
Celiac Disease Foundation Debuts Innovative iRecruitCeliac Patient Recruitment Platform
The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, today announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions. With an established, 30-year track…
ReAlta Life Sciences annuncia una presentazione importante al European Respiratory Society 2023 International Congress
ReAlta Life Sciences, Inc. è un’azienda di biotech clinical-stage impegnata nell’usare la potenza del sistema immunitario per contrastare e risolvere situazioni come malattie rare e malattie infiammatorie acute potenzialmente letali. L’azienda ha oggi annunciato che presenterà ulteriori dati clinica dal…